UPDATE : Monday, February 17, 2020
‘Multinational drugmakers hypocritical in cancer, orphan drug biz’ by Nam Doo-hyun 2018-05-23 15:06
Obesity treatment Saxenda supplied to 10 general hospitals by Nam Doo-hyun 2018-05-23 11:13
Refusals of off-label drugs spiked last year by Nam Doo-hyun 2018-05-17 15:23
How China’s scrapping of tariffs will affect Korea’s drug exports? by Nam Doo-hyun 2018-05-16 12:14
Merck’s Erbitux extends RSA status by Nam Doo-hyun 2018-05-15 14:31
Biotech shares weaken on KONEX, too by Nam Doo-hyun 2018-05-15 14:02
‘Breast cancer drug Faslodex needs insurance coverage’ by Nam Doo-hyun 2018-05-11 11:31
Samsung BioLogics shares recover despite window dressing controversy by Nam Doo-hyun 2018-05-10 11:08
Va-Q-Tec to up investment in Korean biopharmaceuticals by Nam Doo-hyun 2018-05-09 11:54
Pharma, biotech shares tank amid Samsung BioLogics debacle by Nam Doo-hyun 2018-05-08 11:20
How much cheaper will Keytruda be as first-line treatment? by Nam Doo-hyun 2018-05-03 14:51
Will US oncology conference boost Korean biotech shares? by Nam Doo-hyun 2018-04-27 16:29
Guerbet Korea under fire for exploiting monopoly drug by Nam Doo-hyun 2018-04-26 15:37
GC Pharma has most patents among large drug suppliers by Nam Doo-hyun 2018-04-26 11:08
Pharma shares on the rise since early this year by Nam Doo-hyun 2018-04-25 13:56
3 Korean pipelines listed in 537 new drug candidates in US by Nam Doo-hyun 2018-04-24 11:21
Insulin Toujeo beats Tresiba in patient number by Nam Doo-hyun 2018-04-23 16:01
Korean units of GSK, Pfizer send highest dividends to parent firms by Nam Doo-hyun 2018-04-20 14:48
Biotech stocks could be overpriced: analysts by Nam Doo-hyun 2018-04-19 13:34
AstraZeneca up, Novartis down in Q1 outpatient prescriptions by Nam Doo-hyun 2018-04-18 14:58
Back to Top